Low stimulated IL-4 secretion in PBMC from patients with chronic idiopathic urticaria

Ronit Confino-Cohen1, Arnon Goldberg, Dorit Aharoni

  • 1Allergy and Clinical Immunology Unit, Sapir Medical Center, Kefar Saba, affiliated to Sackler School of Medicine, Tel-Aviv University, Israel.

Cytokine
|July 10, 2004
PubMed

Insights

Chronic idiopathic urticaria (CIU) patients show reduced secretion of key immune signaling molecules, specifically Interleukin-4 (IL-4). This suggests a generalized down-regulation of both Th1 and Th2 immune responses in CIU.

Area of Science:

  • Immunology
  • Cellular Immunology

Background:

  • Th1/Th2 immune imbalance is noted in autoimmune diseases.
  • This imbalance has not been previously studied in chronic idiopathic urticaria (CIU).

Purpose of the Study:

  • To investigate the secretion patterns of Th1 (IFNgamma, IL-2) and Th2 (IL-4, IL-10) cytokines in CIU patients.
  • To compare these patterns with acute urticaria (AU) patients and healthy controls.

Main Methods:

  • Peripheral blood mononuclear cells (PBMC) from 19 CIU patients, 6 AU patients, and 12 controls were analyzed.
  • Cytokine secretion (peak, total, and pattern over time) was measured in resting and stimulated PBMC.

Main Results:

  • CIU patients exhibited significantly reduced peak and total secretion of Interleukin-4 (IL-4).
  • The IL-4 secretion pattern over time was markedly different in CIU patients compared to controls.
  • Reduced late secretion of Interferon-gamma (IFNgamma) was observed in CIU patients.
  • IL-2 secretion was lower in both CIU and AU patients versus controls, while IL-10 levels were comparable across groups.

Conclusions:

  • This study is the first to demonstrate predominantly reduced IL-4 secretion in CIU.
  • The findings indicate a generalized down-regulation of both Th1 and Th2 cytokine secretion in CIU.
  • Observed cytokine aberrations were specific to CIU and not present in AU patients.